Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Layer-by-layer assembled antisense DNA microsponge particles for efficient delivery of cancer therapeutics

Authors
Roh, Young HoonLee, Jong BumShopsowitz, Kevin EDreaden, E.C.Morton, Dreaden, Stephen WPoon, ZhiyongHong, JinkeeYamin, InbarBonner, Daniel KHammond, Paula T
Issue Date
Oct-2014
Publisher
American Chemical Society
Keywords
antisense therapy; cancer; DNA delivery; DNA nanotechnology; DNA oligonucleotide; layer-by-layer; multifunctionality
Citation
ACS Nano, v.8, no.10, pp 9767 - 9780
Pages
14
Journal Title
ACS Nano
Volume
8
Number
10
Start Page
9767
End Page
9780
URI
https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/64736
DOI
10.1021/nn502596b
ISSN
1936-0851
1936-086X
Abstract
Antisense oligonucleotides can be employed as a potential approach to effectively treat cancer. However, the inherent instability and inefficient systemic delivery methods for antisense therapeutics remain major challenges to their clinical application. Here, we present a polymerized oligonucleotides (ODNs) that self-assemble during their formation through an enzymatic elongation method (rolling circle replication) to generate a composite nucleic acid/magnesium pyrophosphate sponge-like microstructure, or DNA microsponge, yielding high molecular weight nucleic acid product. In addition, this densely packed ODN microsponge structure can be further condensed to generate polyelectrolyte complexes with a favorable size for cellular uptake by displacing magnesium pyrophosphate crystals from the microsponge structure. Additional layers are applied to generate a blood-stable and multifunctional nanoparticle via the layer-by-layer (LbL) assembly technique. By taking advantage of DNA nanotechnology and LbL assembly, functionalized DNA nanostructures were utilized to provide extremely high numbers of repeated ODN copies for efficient antisense therapy. Moreover, we show that this formulation significantly improves nucleic acid drug/carrier stability during in vivo biodistribution. These polymeric ODN systems can be designed to serve as a potent means of delivering stable and large quantities of ODN therapeutics systemically for cancer treatment to tumor cells at significantly lower toxicity than traditional synthetic vectors, thus enabling a therapeutic window suitable for clinical translation. © 2014 American Chemical Society.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Engineering > School of Chemical Engineering and Material Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE